Grants and Contributions

• Incorporating sex and gender into health research makes for better science that is more rigorous and more applicable to the needs of everybody. The CIHR Institute of Gender and Health (CIHR-IGH) will provide bridge funding for applications that are relevant to its mandate:
o CIHR-IGH mandate is to foster research excellence regarding the influence of sex and gender on health and to apply these findings to identify and address pressing health challenges facing men, women, girls, boys and gender-diverse people.
• These one (1) year operating grants afford Principal Investigators an opportunity to resubmit their research proposal without the loss of momentum, staff, or trainees.

• This Priority Announcement will fund applications that are determined to be relevant to women’s health research, including but not limited to, endometriosis, fibroids, polycystic ovary syndrome, pelvic floor dysfunction, ovarian cancer, non-hormonal female contraception and menopause.
• These one (1) year operating grants afford Early Career Researchers an opportunity to advance their women’s health research program.

• This prize was established to honour the past Scientific Director of the Institute of Aging, Yves Joanette, for his outstanding contributions to the area of research on aging in Canada and internationally.
• This prize will be given annually to the highest ranking funded project in the Project Grant competition that is relevant to one of the Institute of Aging’s Strategic Directions as described below:
o Strategic Direction 1: Health and Wellness over the Trajectory of Aging
Priority Areas:
¿ Life trajectory as a determinant of healthy and satisfying aging
¿ Added life to the later years
o Strategic Direction 2: Facing the Complex Health Challenges of an Older Population
Priority Areas:
¿ Understanding, preventing and addressing multiple chronic conditions
¿ Facing the challenge of dementia
¿ Recognizing new emerging aging populations
¿ Ensuring the adaptation of healthcare and services to an aging population
¿ Informing late-life care and decisions

Cystic Fibrosis Canada has since its beginnings, funded high-quality CF research by Canadian researchers from across the country. We’ve always had the goal to fund the best research that will help advance our understanding of the disease and improve the lives of people with cystic fibrosis. The specific research topics were generally directed by the research interests of the scientists themselves, and by their ability to communicate well the need to fund their particular research questions.

The specific objectives of this funding opportunity are:
• To provide recognition and funding to academic researchers;
• To provide a reliable supply of highly skilled and qualified researchers.

The Banting Postdoctoral Fellowships Program aims to attract and retain top-tier postdoctoral talent, both nationally and internationally, to develop their leadership potential and to position them for success as research leaders of tomorrow, positively contributing to Canada’s economic, social and research-based growth through a research-intensive career.

• CIHR-IG will provide funding for applications that are determined to be relevant to its mandate:
o The Institute of Genetics (IG) supports research on the human and model genomes and on all aspects of genetics, basic biochemistry and cell biology related to health and disease, including the translation of knowledge into health policy and practice, and the societal implications of genetic discoveries

• CIHR-IG will provide funding for applications that are determined to be relevant to its mandate:
o The Institute of Genetics (IG) supports research on the human and model genomes and on all aspects of genetics, basic biochemistry and cell biology related to health and disease, including the translation of knowledge into health policy and practice, and the societal implications of genetic discoveries

• CIHR-IG will provide funding for applications that are determined to be relevant to its mandate:
o The Institute of Genetics (IG) supports research on the human and model genomes and on all aspects of genetics, basic biochemistry and cell biology related to health and disease, including the translation of knowledge into health policy and practice, and the societal implications of genetic discoveries

• The CIHR Institute of Cancer Research (CIHR-ICR) has a mandate to support research that reduces the burden of cancer on individuals and families through prevention strategies, screening, diagnosis, effective treatments, psycho-social support systems, and palliation. This priority announcement will provide funding for applications to support research on decision making when it comes to policies, programs and practices related to cancer care (including screening and prevention) in the following research areas:
o Health Economics and Health Services Research in Cancer Control